Statistics

Total Visits

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment73

Select a period of time:

Number of views in the range

Views
Sorafenib (SOR) in advanced non-small cell lung cancer (NSCLC): A phase II study of patient progress after several lines of treatment28

Views

Views
April 20252
May 20251
June 20250
July 202518
August 20250
September 20255
October 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
Brazil6
United Kingdom4
Kenya2
Ecuador1
Egypt1
Spain1
Panama1
Paraguay1
Senegal1
 

Top cities views

Views
Nairobi2
Alexandria1
Baltimore1
Caraguatatuba1
Ciudad Ojeda1
Council Bluffs1
Dakar1
Dallas1
Duque de Caxias1
Greenwich1